Research Institute: Flinders University and Flinders Medical Centre
Amount granted: $1 million
Year granted: 2005
Feature outcome: construction of a multidisciplinary academic cancer centre to be called The Flinders Centre for Innovation in Cancer, Prevention and Care (FCIC).
The building provides space for research and clinical activities. Funding provided by the Australian Cancer Research Foundation was specifically directed towards the research areas and the fitting out of the research space.
The FCIC has become a facility that is user-friendly for patients and research participants, and which unifies personnel, their activities and programs.
Specifically, in relation to research, it provides environments that facilitate clinical trials, data management, data informatics, multidisciplinary networking in meetings, and new laboratory facilities needed for emerging technologies.
At FCIC, the science focus is specifically on precancer biology – a logical point for developing preventive strategies, whereas most groups focus on cancer itself and relate more to treatment than prevention.
Inherent in this mission, is the capability of translating new technology and knowledge into effective outcomes in both the clinical arena and at the community level.
Examples which have broader capabilities, include: identifying those at risk of developing cancer; enhancing repair of genetic events; diagnosing those with precancer lesions; regulating progression by targeting genomic instability and/or altered biology.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.